Press Releases - Emmaus Medical, Inc.

Emmaus Life Sciences Receives Marketing Authorization for Endari® in OmanJuly 13, 2023

Emmaus today announced that it has received marketing authorization from the Oman Ministry of Health for the commercial distribution and sale of Endari®

Emmaus Life Sciences Receives Endari® Marketing Authorization from the Bahrain NHRAMay 31, 2023

Emmaus has received a Medicine Registration Certificate (DRN-10164/23) from the Bahrain National Health Regulatory Authority (NHRA) granting marketing authorization for the commercial distribution and sale of Endari® in the Kingdom of Bahrain.

Emmaus Life Sciences Reports Q1 2023 Financial Results and Provides Business UpdateMay 15, 2023

Emmaus Life Sciences, Inc. today reported on its financial condition and results of operations as of and for the three months ended March 31, 2023.

Emmaus Life Sciences Provides Interim Shipment DataApril 03, 2023

Emmaus announced today preliminary results for the 3 months that ended March 31, 2023.

Emmaus Life Sciences Reports 2022 Financial Results and Provides Business UpdateMarch 31, 2023

Emmaus Life Sciences, Inc. (OTCQX: EMMA), today reported its results of operation for the year ended December 31, 2022 and an update on recent activities.